In Conversation

We have observed big improvements in terms of trust [in biosimilars] from both healthcare professionals and patients [in Spain] in the last few years

CAR-T is not necessarily the best treatment option for everyone. There could be other second-best options for a certain group of patients. Our point of view…

We are transforming our view from product-based - selling land, sea or air freight - to understanding what the customer needs are and looking at the…

While we are not in capital equipment... we foresee the potential for collaboration with hospitals, using new methods of interaction, such as value-based healthcare, to improve…

Because our clinical and commercial experts live under the same roof, they are able to constantly share real-world knowledge and insights that lead to getting the…

We continue to be the leader in rare diseases and aspire to be the top company in the gastrointestinal and oncology areas wherever we are present

The sector is moving towards outcome- and value-based healthcare, of which diagnostics will have a big part to play

We are assisting in maintaining a high level of employment in the country. We have more than 2,700 employees in Spain

Spanish healthcare devices are highly competitive and, as a group, we are present in over 60 countries

The first step into digitalization is to convince our customers to standardise their systems and the way that they collect data. Without this, we cannot progress

The seawater must be collected from special points in the ocean where there is a lot of phytoplankton, where the marine food chain begins. Because of…

Our issue is that economically Catalonia is a region that excels compared to many other areas of Spain, yet the Spanish government decides and divides the…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here